Journal
PROCESSES
Volume 9, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/pr9010135
Keywords
NAFLD; insulin resistance; metabolic syndrome; cytokines; CV risk
Categories
Ask authors/readers for more resources
Non-alcoholic Fatty Liver Disease (NAFLD) is characterized by fat accumulation in hepatocytes without alcohol consumption, with insulin resistance (IR) playing a key role in its development. A recent expert consensus has suggested using the term Metabolic-Associated Fatty Liver Disease (MAFLD) instead. This disease is associated with an increase in free fatty acid levels and pro-inflammatory cytokines, ultimately leading to insulin resistance and increasing cardiovascular risk.
Non-Alcoholic Fatty Liver Disease (NAFLD) is caused by the accumulation of fat in over 5% of hepatocytes in the absence of alcohol consumption. NAFLD is considered the hepatic manifestation of metabolic syndrome (MS). Recently, an expert consensus suggested as more appropriate the term MAFLD (metabolic-associated fatty liver disease). Insulin resistance (IR) plays a key role in the development of NAFLD, as it causes an increase in hepatic lipogenesis and an inhibition of adipose tissue lipolysis. Beyond the imbalance of adipokine levels, the increase in the mass of visceral adipose tissue also determines an increase in free fatty acid (FFA) levels. In turn, an excess of FFA is able to determine IR through the inhibition of the post-receptor insulin signal. Adipocytes secrete chemokines, which are able to enroll macrophages inside the adipose tissue, responsible, in turn, for the increased levels of TNF-alpha. The latter, as well as resistin and other pro-inflammatory cytokines such as IL-6, enhances insulin resistance and correlates with endothelial dysfunction and an increased cardiovascular (CV) risk. In this review, the role of diet, intestinal microbiota, genetic and epigenetic factors, low-degree chronic systemic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress on NAFLD have been addressed. Finally, the clinical impact of NAFLD on cardiovascular and renal outcomes, and its direct link with type 2 diabetes have been discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available